Key facts
- Loop Diagnostics’s last known valuation is $7.5M (Mar 2023).
- It has raised $6.6M; the latest was Early Stage VC ($5.8M) in Aug 2025.
- Notable investors include Anthology Ventures, Biocat, CIMTI, Cecot Healthcare Pre-Accelerator, Cross4Health — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Loop Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Loop Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Loop Diagnostics
Development of diagnostic devices designed for doctors to detect and diagnose infectious diseases early. The company's devices use a novel methodology and disposable in-vitro cellular immunoassay to identify the immune activity of the patient and diagnose bacterial sepsis, the diagnostic window of the test comprises the first hour of bloodstream infection till the end of the sepsis status, helping healthcare workers with a fast sepsis diagnosis, reducing sepsis mortality, patient side effects and antibiotic resistance due to unnecessary antibiotics.
- Sector
- Healthcare
- HQ
- Soria, Spain
- Employees
- 10
- Website
- loopdx.com/
- Ownership
- Privately Held (backing)
Loop Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Loop Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Loop Diagnostics in its N-PORT filings yet. We sweep new filings monthly.